Five Family Members Traveling from Seoul to Busan All Confirmed with COVID-19

After One Positive Case on the 19th, All Four Family Members Confirmed on the 20th
Health Authorities Struggle with 'Unknown Source' Epidemiological Investigation of Busan618 Infection

On November 18, citizens are waiting to receive COVID-19 diagnostic tests at the screening clinic of Songpa-gu Public Health Center in Seoul. [Yonhap News]

[Asia Economy Yeongnam Reporting Headquarters Reporter Kim Yong-woo] A family of four from Seoul tested positive for COVID-19 in Busan. As of the 20th, the total number of confirmed family members reached five.

They are all family members (Busan cases 619 to 622) of the 'Busan case 618' patient who traveled from Seoul, and the route of infection is unclear, causing difficulties for health authorities in conducting epidemiological investigations.

Busan City announced that as of 10 a.m. on the 20th, four additional COVID-19 patients were confirmed compared to the previous day, bringing the cumulative number of cases in Busan to 622.

The Busan case 618 patient, who resides in Seoul, developed symptoms after traveling to Busan and was confirmed positive on the 19th after visiting a screening clinic.

Busan health authorities are investigating the onset of symptoms and movement paths to identify the infection route.

Earlier, symptoms first appeared in the Busan case 618 patient, and four family members classified as contacts tested positive in diagnostic tests.

Among the 622 cumulative cases in Busan, 35 patients are hospitalized and receiving treatment at Busan Medical Center (24 patients) and Pusan National University Hospital (11 patients). A total of 572 patients have been released from isolation after recovery, and 15 have died.

On the previous day, 617 suspected patient tests were conducted in Busan. Additionally, 220 overseas arrivals entered the city in one day. The total number of people under self-quarantine is 3,324.

This content was produced with the assistance of AI translation services.